Within-Person Blood Pressure Variability During Hospitalization and Clinical Outcomes Following First-Ever Acute Ischemic Stroke

Overview

Journal Am J Hypertens

Publisher Oxford University Press

Specialty Cardiology & Vascular Diseases

Date 2022 Sep 21

PMID 36130108

Authors

Mohammed Yousufuddin

M H Murad

Jessica L Peters

Taylor J Ambriz

Katherine R Blocker

Kanika Khandelwal

Sandeep R Pagali

Sanjeev Nanda

Ahmed Abdalrhim

Urvish Patel

Sagar Dugani

Kogulavadanan Arumaithurai

Paul Y Takahashi

Kianoush B Kashani

Affiliations

Soon will be listed here.

Abstract

Background: Uncertainty remains over the relationship between blood pressure (BP) variability (BPV), measured in hospital settings, and clinical outcomes following acute ischemic stroke (AIS). We examined the association between within-person systolic blood pressure (SBP) variability (SBPV) during hospitalization and readmission-free survival, all-cause readmission, or all-cause mortality 1 year after AIS.

Methods: In a cohort of 862 consecutive patients (age [mean ± SD] 75 ± 15 years, 55% women) with AIS (2005-2018, follow-up through 2019), we measured SBPV as quartiles of standard deviations (SD) and coefficient of variation (CV) from a median of 16 SBP readings obtained throughout hospitalization.

Results: In the cumulative cohort, the measured SD and CV of SBP in mmHg were 16 ± 6 and 10 ± 5, respectively. The hazard ratios (HR) for readmission-free survival between the highest vs. lowest quartiles were 1.44 (95% confidence interval [CI] 1.04-1.81) for SD and 1.29 (95% CI 0.94-1.78) for CV after adjustment for demographics and comorbidities. Similarly, incident readmission or mortality remained consistent between the highest vs. lowest quartiles of SD and CV (readmission: HR 1.29 [95% CI 0.90-1.78] for SD, HR 1.29 [95% CI 0.94-1.78] for CV; mortality: HR 1.15 [95% CI 0.71-1.87] for SD, HR 0.86 [95% CI 0.55-1.36] for CV).

Conculsions: In patients with first AIS, SBPV measured as quartiles of SD or CV based on multiple readings throughout hospitalization has no independent prognostic implications for the readmission-free survival, readmission, or mortality. This underscores the importance of overall patient care rather than a specific focus on BP parameters during hospitalization for AIS.

References

Smith T, Sillito J, Goh C, Abdel-Fattah A, Einarsson A, Soiza R . Association between different methods of assessing blood pressure variability and incident cardiovascular disease, cardiovascular mortality and all-cause mortality: a systematic review. Age Ageing. 2020; 49(2):184-192. DOI: 10.1093/ageing/afz178. View

Hansen T, Li Y, Staessen J . Blood pressure variability remains an elusive predictor of cardiovascular outcome. Am J Hypertens. 2008; 22(1):3-4. DOI: 10.1038/ajh.2008.322. View

Yousufuddin M, Bartley A, Alsawas M, Sheely H, Shultz J, Takahashi P . Impact of Multiple Chronic Conditions in Patients Hospitalized with Stroke and Transient Ischemic Attack. J Stroke Cerebrovasc Dis. 2017; 26(6):1239-1248. DOI: 10.1016/j.jstrokecerebrovasdis.2017.01.015. View

Greenberg S, Ziai W, Cordonnier C, Dowlatshahi D, Francis B, Goldstein J . 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2022; 53(7):e282-e361. DOI: 10.1161/STR.0000000000000407. View

Lim H, Chia Y, Ching S, Chinna K . Number of blood pressure measurements needed to estimate long-term visit-to-visit systolic blood pressure variability for predicting cardiovascular risk: a 10-year retrospective cohort study in a primary care clinic in Malaysia. BMJ Open. 2019; 9(4):e025322. PMC: 6500269. DOI: 10.1136/bmjopen-2018-025322. View

Zhu J, Chen N, Zhou M, Guo J, Zhu C, Zhou J . Calcium channel blockers versus other classes of drugs for hypertension. Cochrane Database Syst Rev. 2022; 1:CD003654. PMC: 8742884. DOI: 10.1002/14651858.CD003654.pub6. View

Arashi H, Ogawa H, Yamaguchi J, Kawada-Watanabe E, Hagiwara N . Impact of visit-to-visit variability and systolic blood pressure control on subsequent outcomes in hypertensive patients with coronary artery disease (from the HIJ-CREATE substudy). Am J Cardiol. 2015; 116(2):236-42. DOI: 10.1016/j.amjcard.2015.04.011. View

Wizner B, Dechering D, Thijs L, Atkins N, Fagard R, OBrien E . Short-term and long-term repeatability of the morning blood pressure in older patients with isolated systolic hypertension. J Hypertens. 2008; 26(7):1328-35. DOI: 10.1097/HJH.0b013e3283013b59. View

Wallace J, LEVY L . Blood pressure after stroke. JAMA. 1981; 246(19):2177-80. View

10.

Einstadter D, Bolen S, Misak J, Bar-Shain D, Cebul R . Association of Repeated Measurements With Blood Pressure Control in Primary Care. JAMA Intern Med. 2018; 178(6):858-860. PMC: 6061958. DOI: 10.1001/jamainternmed.2018.0315. View

11.

Nepal G, Shrestha G, Shing Y, Muha A, Bhagat R . Systolic blood pressure variability following endovascular thrombectomy and clinical outcome in acute ischemic stroke: A meta-analysis. Acta Neurol Scand. 2021; 144(4):343-354. DOI: 10.1111/ane.13480. View

12.

Sandset E, Bath P, Boysen G, Jatuzis D, Korv J, Luders S . The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet. 2011; 377(9767):741-50. DOI: 10.1016/S0140-6736(11)60104-9. View

13.

Stevens S, McManus R, Stevens R . The utility of long-term blood pressure variability for cardiovascular risk prediction in primary care. J Hypertens. 2018; 37(3):522-529. DOI: 10.1097/HJH.0000000000001923. View

14.

Mancia G, Grassi G . Mechanisms and clinical implications of blood pressure variability. J Cardiovasc Pharmacol. 2001; 35(7 Suppl 4):S15-9. DOI: 10.1097/00005344-200000004-00003. View

15.

Tziomalos K, Giampatzis V, Bouziana S, Spanou M, Kostaki S, Papadopoulou M . No Association Observed Between Blood Pressure Variability During the Acute Phase of Ischemic Stroke and In-Hospital Outcomes. Am J Hypertens. 2015; 29(7):841-6. DOI: 10.1093/ajh/hpv191. View

16.

Rothwell P, Howard S, Dolan E, OBrien E, Dobson J, Dahlof B . Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010; 375(9718):895-905. DOI: 10.1016/S0140-6736(10)60308-X. View

17.

Stanistreet B, Nicholas J, Bisognano J . An Evidence-Based Review of Elevated Blood Pressure for the Inpatient. Am J Med. 2019; 133(2):165-169. DOI: 10.1016/j.amjmed.2019.10.004. View

18.

Webb A, Fischer U, Mehta Z, Rothwell P . Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 2010; 375(9718):906-15. DOI: 10.1016/S0140-6736(10)60235-8. View

19.

Muntner P, Whittle J, Lynch A, Colantonio L, Simpson L, Einhorn P . Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study. Ann Intern Med. 2015; 163(5):329-38. PMC: 5021508. DOI: 10.7326/M14-2803. View

20.

Kollias A, Stergiou G, Kyriakoulis K, Bilo G, Parati G . Treating Visit-to-Visit Blood Pressure Variability to Improve Prognosis: Is Amlodipine the Drug of Choice?. Hypertension. 2017; 70(5):862-866. DOI: 10.1161/HYPERTENSIONAHA.117.10087. View